Přispěvatelé: |
BARCELLOS LF, SAWCER S, RAMSAY PP, BARANZINI SE, THOMSON G, BRIGGS F, CREE BC, BEGOVICH AB, VILLOSLADA P, MONTALBAN X, UCCELLI A, SAVETTIERI G, LINCOLN RR, DELOA C, HAINES JL, PERICAK-VANCE MA, COMPSTON A, HAUSER SL, OKSENBERG JR |
Popis: |
Variation in major histocompatibility complex genes on chromosome 6p21.3, specifically the human leukocyte antigen HLA-DR2 or DRB1*1501-DQB1*0602 extended haplotype, confers risk for multiple sclerosis (MS). Previous studies of DRB1 variation and both MS susceptibility and phenotypic expression have lacked statistical power to detect modest genotypic influences, and have demonstrated conflicting results. Results derived from analyses of 1339 MS families indicate DRB1 variation influences MS susceptibility in a complex manner. DRB1*15 was strongly associated in families (P=7.8x10(-31)), and a dominant DRB1*15 dose effect was confirmed (OR=7.5, 95% CI=4.4-13.0, P |